Insufficient Oxygenation in Septic Patients
Sponsored by Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research
About this trial
Last updated 2 years ago
Study ID
Status
Type
Placebo
Accepting
Trial Timing
Ended 3 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
* Age of patient is at least 18 years
* Patients diagnosed with sepsis in the emergency department or hospital ward
* Patients are admitted to the ICU via the hospital ward or emergency department
* Informed consent is given either by the patient or if the patient is too ill to give informed consent, by his or her legal representative.
* Patients have an arterial catheter in situ, since blood samples will be taken for the study. Most patients admitted to the ICU have an arterial catheter in place since it is part of standard care.
Exclusion Criteria
* Patients younger than 18 years
* Patients with sepsis discharged after emergency department visit
* Patients admitted to a hospital ward other than the ICU after emergency department visit
* Patients who cannot give informed consent themselves and without a legal representative will be excluded since no informed consent can be obtained
* Patients known with porphyria and/or photodermatosis will be excluded, since the risk of phototoxicity
* Patients with hypersensitivity to the active substance or to the plaster material of ALA (5-aminolevulinic acid)
* Pregnant or breast feeding women since there is no adequate data form the use of ALA in pregnant or breast feeding women
* Insufficient comprehensibility of the Dutch language
